Enhancing & Accurately Validating Delivery to the Brain for a Novel Nasal Anti-Epileptic Formulation

Time: 12:00 pm
day: Conference Day One


  • Formulation approaches and device considerations for early stage development of a novel anti-epileptic
  • Developing a robust analytical strategy to produce promising, translatable results from mouse models
  • Employing blood biomarkers to precisely trace drug migration to the target areas of the brain